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Abstract  
Background: Internationally, non-malignant respiratory disease (NMRD) is on the increase. 
However, although palliative care is recommended as an appropriate healthcare option for 
this client group, evidence suggests that these patients and their carers do not receive the 
same standards of palliative care as patients with a malignant lung condition.  
Aim: The aim of this review was to provide a critical overview of the current evidence base 
in relation to the palliative service provision for people with NMRD and their carers.   
Methods: A review of the literature was conducted in July 2015 and updated in October 
2017, focused on the palliative care service provision for patients with interstitial lung 
disease, COPD and bronchiectasis.  
Results: Seventy-one empirical studies were included in the review and grouped in to two 
main themes: Patient and carer’s bio-psychosocial symptom needs and management, and 
Palliative care service provision for patients with non-malignant respiratory disease and their 
carer.  
Conclusion: The majority of palliative research focuses on patients with a diagnosis of 
COPD. A deeper insight is required into the palliative service provision experienced by those 
with other forms of non-malignant respiratory disease such as bronchiectasis and interstitial 
lung disease.  
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Introduction 
The World Health Organization (WHO) (2002) define palliative care as a holistic approach to 
the care of those with a life limiting illness and their carers, that relieves and prevents 
suffering through the early identification and assessment of physical, psychological, social 
and spiritual symptoms. Originally, the only patients who had access to palliative care 
services were those with a diagnosis of cancer and nearing the end of their life. More recently 
however, it has been recognised that palliative care is also applicable to patients with a non-
malignant disease, not just malignant disease (Mitchell et al. 2012), and is an integral part of 
a patient’s disease management (O’Neill and Fallon 1997) from diagnosis.   
 
Non- Malignant Respiratory Disease (NMRD) is an umbrella term that includes conditions 
such as Interstitial Lung Disease (ILD), bronchiectasis and Chronic Obstructive Pulmonary 
Disease (COPD) (National End of Life Care Intelligence Network 2011). Two hundred and 
ten million people worldwide have a diagnosis of COPD and, although the exact amount is 
not known, it is estimated that millions of others have other forms of chronic respiratory 
diseases such as ILD and bronchiectasis (WHO 2008). Non-malignant respiratory disease is a 
chronic, non-curable, progressive illness that requires appropriate treatment and palliative 
symptom management. Healthcare professionals (HCPs) provide palliative care in order to 
help improve the physical, psychosocial and spiritual well-being of patients with a life-
limiting illness, and their families (Mc Veigh 2016). The palliative care provided by HCPs 
that specialise in this area is known as specialist palliative care, and these professionals 
provide palliative expertise, services and resources (Faull and Blankley 2015). Generalist 
palliative care providers are HCPs who provide patients with palliative care however are not 
defined as specialists due to not having received accredited palliative care training (Gott et al. 
2012). Although NMRD is on the increase internationally and nationally, evidence suggested 
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that patients with NMRD and their carers do not receive the same standards of palliative care 
as patients with malignant respiratory disease (Goodridge et al. 2008: Partridge et al. 2009). 
The overall aim of this literature review was to critically discuss the current evidence base in 
relation to the palliative service provision for people with NMRD and their carers.  
 
Literature Review  
The search strategy within this literature review is described in Figure 1. Papers were 
excluded that did not meet the inclusion criteria (table 1). Empirical research papers were 
evaluated with guidance from the Critical Appraisal Skills Programme (CASP) critical 
appraisal tools (CASP UK 2012), to ensure a systematic and rigorous approach (Aveyard 
2014). The CASP critical appraisal tools provided an evidence-based approach to assess the 
quality, quantity and consistency of the specific research designs employed by the empirical 
research included in the review (CASP UK). The literature was also additionally appraised by 
discussions with the research team. The use of themes was chosen by the researcher to 
appropriately identify the most commonly occurring issues in the literature (Aveyard 2010).  
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Figure 1: Flow diagram demonstrating the search strategy involving 3 stages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STAGE ONE 
KEY TERMS 
• Care* OR Family OR Patient OR Healthcare Professional OR Client OR People 
AND 
• COPD OR Chronic Obstructive Pulmonary Disease  OR Bronchiectasis OR Pulmonary 
Fibrosis OR Interstitial Lung Disease OR Sarcoidosis 
AND 
•  “Palliative Care”  OR “Terminal care” OR “End of Life Care”  OR “Hospice Care” 
DATABASES SEARCHED TOGETHER 
(277 papers) 
• CINAHL Plus, MEDLINE, Web of Science, Cochrane Database of 
Systematic Reviews, PsychINFO and PsychMed.  
Databases searched individually 
(0 new papers) 
STAGE TWO 
Exclusion criteria applied resulting in 70 papers being included in review  
STAGE THREE 
Reference lists of relevant studies searched (0 new papers) 
36 Qualitative  
Papers 
Reviewed 
34 Quantitative 
Papers 
Reviewed 
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Table 1: Table outlining the inclusion criteria and exclusion  
INCLUSION CRITERIA 
 Papers that were written in English 
 Papers that specifically referred to non-malignant respiratory disease  
 Papers published no more than ten years previous to date of initial database 
search 
 Papers that specifically referred to palliative, hospice, terminal or end of life 
care 
EXCLUSION CRITERIA 
 Papers that were not written in English 
 Papers that did not specifically refer to non-malignant respiratory disease 
 Papers published more than ten years previous to date of initial database 
search 
 Papers that did not specifically refer to palliative, hospice, terminal or end of 
life care 
 
In total 70 international papers informed the literature review: 34 quantitative and 36 
qualitative. Each empirical paper was explored and the two themes that emerged from the 
literature were:: Patient and carer’s bio-psychosocial symptom needs and management and 
Palliative care service provision for patients with NMRD and their carer.  
 
Patient and carer’s bio-psychosocial symptom needs and management  
There are a number of complex symptoms associated with NMRD which can lead to reduced 
quality of life for these patients and their carers. Breathlessness is the symptom most 
commonly experienced by patients with a diagnosis of NMRD and is often the symptom 
found to be most distressing and severe (Ek and Ternestedt 2008: Gysels and Higginson 
2008: Habraken et al. 2008: Blinderman et al. 2009: Bausewein et al. 2010: White et al. 
2011: Janssen et al. 2011: Bajwah et al. 2013).  For patients with advanced COPD, 
breathlessness can cause increased disability and impact on their quality of life (Blinderman 
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et al. 2009). Gysels and Higginson (2008) argued that breathlessness can prevent patients 
with COPD from accessing services. Their research involved semi-structured interviews 
conducted with 18 patients diagnosed with moderate or severe COPD, who were 
experiencing problems regarding their breathlessness. Gysels and Higginson conveyed that 
patients had come to just adapt to their breathlessness and its restrictions as it had gradually 
worsened from the start of their illness.  They also concluded that patients tried to hide how 
bad their breathlessness was as they associated it with smoking and feared that the public, and 
healthcare professionals (HCPs), would judge the cause of breathlessness as self-inflicted. 
Participants additionally expressed that they were given little advice on how to manage their 
symptoms and were also offered limited treatment options. Gysel and Higginson and 
previous research (Hasson et al. 2008: Ek and Ternestedt 2008) have emphasised the 
importance of a palliative care approach for patients with advanced COPD. 
 
Breathlessness is a symptom not isolated to patients with COPD as it can also be experienced 
by patients with other forms of NMRD. Bajwah et al. (2013) highlighted that patients with 
Idiopathic Pulmonary Fibrosis (IPF), a form of ILD, also experienced severe breathlessness 
due to their condition. Bajwah et al. conducted 18 qualitative interviews with patients with 
advanced IPF, their carers and HCPs involved in their care from two specialist ILD clinics in 
the UK. However, previous evidence highlighted that patients with ILD experienced multiple 
symptoms, alongside breathlessness, that were related to their illness (Bajwah et al. 2012). 
Bajwah et al. previously completed a retrospective analysis of the case notes of 45 patients 
with IPF who had died up to 17 months previously in the UK. This study aimed to assess the 
palliative care symptom needs of patients with IPF, and demonstrated that 93% of 
participants experienced breathlessness in their last year of life, 60% experienced a cough, 
29% experienced chest pain, 29% experienced fatigue and 22% experienced depression or 
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anxiety. However as this study involved a retrospective chart review, caution must be taken 
in interpreting these results as some of the symptoms experienced by patients with IPF may 
not have been fully documented.  
 
Although breathlessness is typically the main symptom associated with NMRD, patients also 
experience psychosocial symptoms (Janssen et al. 2011: White et al. 2011: Philip et al. 2012: 
Stenzel et al.2015). White et al. (2011) carried out a cross- sectional quantitative study in the 
UK involving 163 patients with severe COPD. Results illuminated that 35% (95% CI) of the 
participants were at a high risk of anxiety, and 43% (95% CI) were at a high risk of 
depression. Similarly, Janssen et al. (2011) highlighted that 28% of participants experienced 
depression, alongside other as physiological symptoms. Janssen et al. carried out an 
observational study in Holland involving 105 outpatients with severe COPD.  Results 
additionally demonstrated that the majority of participants were unaware of the interventions 
that were available to them to aid both psychological and physiological symptom 
management, including medication and treatment provided by HCPs.  
 
There have been several studies that have explored the needs and experiences of carers of 
patients with a NMRD diagnosis (Spence et al. 2008: Hasson et al. 2009: Gysels and 
Higginson 2008: Hynes et al. 2012: Simpson et al. 2010: Philip et al. 2014). Caring for a 
patient with advanced COPD can have a physical and psychological impact on the carer 
(Philip et al. 2014) and they therefore require support from HCPs (Kanervisto et al. 2007). 
Philip et al. conducted semi-structured interviews in Australia with active (n=9) and bereaved 
(n=10) carers of patients with severe COPD. Findings demonstrated that many participants 
expressed that they had not chosen to be a carer. This related to the perception from 
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participants that the support they provided the patient initially, had gradually developed into 
them having a significant caring role however there was no alternative to this role as they 
were the patient’s sole carer. Results also indicated that the carer burden participants 
experienced increased as the patients illness progressed and their needs became more 
complex. Philip et al. also stated that many carers felt their caring role had a psychosocial 
impact on their health as they felt isolated and unprepared within their role, and experienced 
anxiety. Healthcare professionals need to recognise the bio-psychosocial needs of carers of 
patients with severe COPD, and be able to manage them appropriately. 
 
Previous research has also highlighted that the palliative care needs, and symptom burden, of 
patients diagnosed with severe COPD (Habraken et al. 2009: Bausewein et al. 2010: 
Weingaertner et al. 2014: Wysham et al. 2015: Maric et al. 2016) and ILD (Matsunuma et al. 
2016) may be as high as those with advanced lung cancer. Bausewein et al. conducted a cross 
sectional study in Germany involving 49 patients with cancer and 60 with COPD. 
Participants in the study completed questionnaires to measure their physical and 
psychological symptoms, as well as their palliative care needs. Bausewein et al. 
acknowledged that both groups had similarly high symptom burden and ascertained that the 
most prevalent symptoms in both groups were: breathlessness (42% cancer, 58% COPD): 
fatigue (41% cancer, 43% COPD): and cough (38% cancer, 37% COPD). Although this study 
aimed to recruit patients from hospitals, homes and respiratory clinics, the majority of 
participants were from an in-patient setting. This may have affected the generalisability of the 
study as the perspectives of patients within the primary care setting were lacking. 
Additionally, patients within the acute hospital setting may have been admitted with an 
exacerbation of their condition and therefore may have experienced greater symptom burden. 
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However, Bausewein et al. demonstrated that patients with COPD had considerable symptom 
burden comparable to patients with advanced cancer. 
 
Evidence also suggested that NMRD can cause disease uncertainty amongst patients, family 
carers and HCPs (Gott et al. 2009: Pinnock et al. 2011: Ek et al.2015: Sampson et al. 2015).  
Pinnock et al. (2011) explored the perceptions of HCPs, patients and informal caregivers 
regarding advanced COPD. Pinnock et al. (2011 p.5) highlighted that patients with COPD 
conveyed a ‘chaos narrative’ of their disease. The patient’s condition fluctuated from illness 
to wellness leaving them unsure of how their illness would progress. Conversely, Bajwah et 
al. (2012) suggested that the ILD trajectory aided patients with this form of NMRD, and their 
carers, to understand the life-limiting nature of their condition due to its rapid progression. 
Bajwah reported that as the patient’s condition worsened they became aware of the life-
limiting nature of ILD. However, an all-Ireland qualitative study involving 17 bereaved 
carers of patients with NMRD and 18 HCPs reported that patients with ILD and their carers 
were often unprepared for the rapid deterioration of their condition (Mc Veigh et al. 2017a). 
Mc Veigh et al. illuminated that this rapid deterioration did not provide any further clarity 
into the life-limiting nature of the disease.   
 
Palliative care service provision for patients with NMRD and their carer 
Optimal and effective health service provision plays a key role in the delivery of effective 
palliative care to patients with NMRD and their carers. However research has shown that 
patients with NMRD, and their carers, do not always receive the palliative service provision 
they require (Fitzsimons et al. 2007: Goodridge et al. 2008: Gysels and Higginson 2008: 
Habraken et al. 2008: Hasson et al. 2008: Roberts et al. 2008: Partridge et al. 2009: Buxton 
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et al. 2010: Goodridge et al. 2010: Janssen et al. 2011: Pinnock et al. 2011: Mc Veigh et al. 
2017a: Mc Veigh et al. 2017b: Rush et al. 2017). Roberts et al. (2008) conducted a survey 
involving 100 acute NHS hospitals across the UK investigating the existing care, and quality 
of this care, available to patients with COPD. This survey highlighted that less than 50% of 
the hospitals involved had specialist palliative care services available in their area that 
included patients with COPD, leading to poor access to local specialist palliative care 
provision for this client group. This study’s main limitation however, was that it sought the 
opinions of lead respiratory physicians who may have only provided what they perceived to 
be best practice.  
 
In the UK, patients with NMRD can often have less access to specialist palliative care than 
those with a malignant lung disease (Partridge et al. 2009). Partridge et al. carried out a study 
across England, Wales and NI in which 107 respiratory physicians completed a questionnaire 
regarding specialist palliative care services for patients with NMRD.  Findings indicated that 
patients with severe NMRD had less overall access to specialist palliative care services 
(21.5%) than those with lung cancer. The study reported that although two-thirds of hospital 
inpatients, inclusive of NMRD, could easily access specialist palliative care advice, there was 
less accessibility related to palliative medicine out-patient services.   Also, only a small 
number of physicians involved in the study reported easy access to hospice day or inpatient 
care for patients with NMRD. The study’s reliability may be questioned as the validity of the 
questionnaire is not discussed. Also, as previously mentioned in relation to other studies, its 
results were based on the views of respiratory physicians alone and the study may have 
gained a greater insight into this phenomenon by involving other members of the 
multidisciplinary team.  
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The geographical area a patient diagnosed with NMRD lives in can also influence the level of 
palliative care service provision they receive (Goodridge et al. 2010). Goodridge et al. (2010) 
undertook a cohort study retrospectively investigating the healthcare data of 1098 patients 
who died of a respiratory illness in Canada. This was a novel study as it aimed to examine the 
rural-urban differences in healthcare utilisation, or location of death for patients who died of 
COPD or lung cancer. Results conveyed that patients in their last year of life living in rural 
areas were less likely to receive physician visits and home care services than those in urban 
areas. However, this study did not investigate the reasons for the differences in the palliative 
care provided in rural and urban areas. Palliative care provision for NMRD in rural and urban 
areas needs to be further explored, and future research should not only take into account the 
patients and carers perspective but also the views of HCPs regarding the delivery of 
generalist and specialist palliative care to these patients. This will help to provide an insight 
into what are the barriers and facilitators associated with providing care to patients with 
NMRD in rural and urban areas.  
 
Higginson et al. (2014) conducted a randomised controlled trial (RCT) in the UK assessing 
the effectiveness of integrating specialist palliative care early for patients with advanced  
disease.  Fifty- four percent of participants had a diagnosis of COPD (n = 57), 20% cancer 
(n=21), 18 % ILD (n = 19), 5% heart failure (n=5) and 3% had another form of advanced 
disease (n-=3). The involvement of specialist palliative care early in the disease trajectory of 
patients with ILD can help manage their physiological and psychosocial symptoms 
(Higginson et al. ). This RCT demonstrated that patients with ILD and COPD who received 
early specialist palliative care involvement experienced alleviated breathlessness and 
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increased short term survival: 100% (n=29) vs. 79% (n=22) for COPD, and 100% (n=7) vs. 
67% (n = 8) for ILD at 180 days post commencement of the study. Further investigation with 
this population is required however to illuminate the effects of early specialist palliative care 
on long term survival, findings that have previously been identified in patients with lung 
cancer (Temel et al. 2010). Although previous research has recommended the involvement of 
specialist palliative care for patients with ILD (Bajwah et al. 2012: Bajwah et al. 2013: 
Higginson et al. 2014), referrals to specialist care are often low for this patient group(Bajwah 
et al. 2013: Lindell et al. 2015: Mc Veigh et al. 2017). Mc Veigh et al. illuminated that this is 
often attributed to HCPs lack of awareness of the role of palliative care for this client group.  
  
Some research has provided evidence of ways in which optimal palliative care service 
provision can be provided to patients with NMRD (Janssen et al. 2010: Farquhar et al. 2016: 
Mc Veigh et al. 2017b).  Janssen et al. provided details of three case studies of patients 
diagnosed with COPD or ILD who were part of a patient centred interdisciplinary palliative 
care program specifically for patients with end-stage NMRD in the Netherlands. The 
programme involved the daily management of patients’ symptoms by a team consisting of 
both specialist and generalist palliative care providers. Janssen et al. argued that results 
demonstrated how a palliative care program may have helped to improve the patient’s quality 
of life, reduced their need for hospital admissions and supported patients with NMRD in 
achieving a better quality of death through the appropriate management of symptoms such as 
breathlessness. However this research was not inclusion of all forms of NMRD. Mc Veigh et 
al. (2017b) highlighted a potential model of palliative care for patients with NMRD, inclusive 
of bronchiectasis. The potential model was derived from the findings of qualitative interviews 
with bereaved carers of patients with NMRDs, and focus group with HCPs. This model 
proposed three levels of holistic care for this client group, highlighting the importance of the 
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involvement of generalist palliative care and specialist respiratory care providers in the care 
of patients with NMRD from diagnosis. It additionally proposed that the need for specialist 
palliative care involvement should be assessed throughout the illness trajectory, and involved 
based on symptom complexity. However, Janssen et al. and Mc Veigh et al. argued the need 
for further interventional research to explore the implementation of these models of palliative 
care in clinical practice.  
 
Conclusions 
Evidence suggested disparities in the provision of specialist and generalist palliative care to 
patients with NMRD, in comparison to those with a malignant diagnosis. This review of the 
literature has highlighted that there are several gaps in the current research involving the 
palliative care provided to patients with NMRD.  Further research is required to provide a 
deeper insight into the palliative care provision experienced by those diagnosed with ILD and 
Bronchiectasis alongside COPD, as the majority of research investigates COPD alone.  
 
Key Points 
 Evidence suggested that patients with NMRD and their carers do not receive the same 
standards of palliative care as patients with malignant respiratory disease. 
 Family caregivers also require holistic care. 
 There is a lack of evidence regarding palliative care for ILD and bronchiectasis. 
 Future policy needs to acknowledge the role of palliative care for patients with all 
forms of NMRD, and their carers, and ensure optimal implementation in clinical 
practice.  
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